NDC 0781-2141

aspirin and dipyridamole

Aspirin And Dipyridamole

aspirin and dipyridamole is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sandoz Inc. The primary component is Aspirin; Dipyridamole.

Product ID0781-2141_73b19471-122b-4fe6-8d51-4f217b13557f
NDC0781-2141
Product TypeHuman Prescription Drug
Proprietary Nameaspirin and dipyridamole
Generic NameAspirin And Dipyridamole
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2020-07-24
Marketing CategoryANDA /
Application NumberANDA206739
Labeler NameSandoz Inc
Substance NameASPIRIN; DIPYRIDAMOLE
Active Ingredient Strength25 mg/1; mg/1
Pharm ClassesPlatelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Drug Details

NDC Crossover Matching brand name "aspirin and dipyridamole" or generic name "Aspirin And Dipyridamole"

NDCBrand NameGeneric Name
0093-3040Aspirin and DipyridamoleAspirin and Dipyridamole
0093-3064Aspirin and DipyridamoleAspirin and Dipyridamole
0115-1711aspirin and dipyridamoleaspirin and dipyridamole
0781-2141aspirin and dipyridamoleaspirin and dipyridamole
16714-964Aspirin and DipyridamoleAspirin and Dipyridamole
43598-339Aspirin and DipyridamoleAspirin and Dipyridamole
70436-092aspirin and dipyridamoleaspirin and dipyridamole
0597-0001Aggrenoxaspirin and dipyridamole
21695-656Aggrenoxaspirin and dipyridamole
68151-3971Aggrenoxaspirin and dipyridamole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.